top of page

Acute Viral Hepatitis Screen

£239

Acute Viral Hepatitis Screen

Acute Viral Hepatitis Screen

This is a Hepatitis screen which looks for the following:


Hepatitis A

Hepatitis A is a viral infection that primarily affects the liver and is typically transmitted through contaminated food or water. Testing for hepatitis A is crucial to confirm the diagnosis, assess the severity of the infection, and guide appropriate management. It helps identify individuals who may require treatment, monitor liver function, and prevent the spread of the virus to others. Timely testing is essential for prompt intervention, vaccination of close contacts, and implementation of preventive measures in affected communities or outbreaks.


Hepatitis B

Hepatitis B is a viral infection that affects the liver and can lead to chronic liver disease, including cirrhosis and liver cancer. Testing for hepatitis B is essential to diagnose the infection, assess the stage of the disease, and determine the need for treatment or monitoring. It helps identify individuals who are carriers of the virus, evaluate liver function, and guide preventive measures such as vaccination for at-risk individuals. Testing is crucial for early intervention, preventing transmission, and managing the long-term consequences of hepatitis B infection.


Hepatitis C

Hepatitis C is a viral infection that primarily affects the liver and can lead to chronic liver disease, cirrhosis, and liver cancer. Testing for hepatitis C is vital to diagnose the infection, assess the extent of liver damage, and determine the appropriate treatment options. It helps identify individuals who are chronically infected, guide antiviral therapy decisions, and monitor treatment response. Testing also plays a significant role in preventing transmission and implementing preventive measures to reduce the burden of hepatitis C in communities

Biomarkers:

Hepatitis A is a viral infection that primarily affects the liver and is typically transmitted through contaminated food or water. IgG and IgM are types of antibodies produced by the immune system in response to infections or other foreign substances. IgM antibodies are typically the first to be produced during an acute infection, while IgG antibodies are produced later and provide long-term immunity. Testing for IgG and IgM antibodies is significant in diagnosing and monitoring infectious diseases. IgM testing helps identify recent or active infections, while IgG testing indicates past infection or immunity. Combined IgG and IgM testing provides valuable information for accurate diagnosis, treatment decisions, and monitoring immune response.

Hepatitis B Surface Antigen (HBsAg) are produced in the body by the hepatitis B virus. It is a virus which causes a liver infection and is spread from contact with the blood and bodily fluids of an infected person. HBsAg tests are used to diagnose if a person is currently infectious.

Hepatitis C Antibodies (HCAg) are produced by the immune system after exposure to hepatitis C. Hepatitis C is a virus which causes a liver infection and is spread from contact with the blood of an infected person. HCAg tests are used to determine whether a person has previously been exposed to hepatitis C.

Hepatitis C Antigen, Hep C is a viral infection that primarily affects the liver and can lead to chronic liver disease, cirrhosis, and liver cancer. Testing for hepatitis C antigen is used to see if a person is currently infectious.

Turnaround time:

2-5 Working Days

Note:

This service is only available to the age of 13 and above.


Furthermore, Any cancellation or rescheduling within 48 hours before the appointment will incur a charge of 20% of the total service cost and missed appointments will be deemed non-refundable.



bottom of page